Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Molecular Cancer Therapeutics|May 30, 2006
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistanceXinjian Lin, Stephen B HowellMetal-Based Drugs|January 29, 2011
Regulation of Cisplatin cytotoxicity by cu influx transportersPaolo Abada, Stephen B HowellCritical Reviews in Oncology/Hematology|December 21, 2004
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugsRoohangiz Safaei, Stephen B HowellCancer Chemotherapy and Pharmacology|September 20, 2005
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transportersGoli Samimi, Stephen B HowellPlos One|January 30, 2014
Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cellsPaolo B Abada, Stephen B HowellMolecular Pharmaceutics|December 10, 2009
CD44-targeted microparticles for delivery of cisplatin to peritoneal metastasesShyh-Dar Li, Stephen B HowellCancer Research|November 17, 2006
The internalization and degradation of human copper transporter 1 following cisplatin exposureAlison K Holzer, Stephen B HowellCell Communication and Signaling : CCS|October 26, 2014
Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-cateninXiying Shang, Xinjian Lin, Stephen B HowellBiochimica Et Biophysica Acta|October 26, 2007
NMR and mutagenesis of human copper transporter 1 (hCtr1) show that Cys-189 is required for correct folding and dimerizationSangwon Lee, Stephen B Howell, Stanley J OpellaPlos One|March 8, 2023
Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphomaHimangshu Sonowal, William G Rice, Stephen B HowellPageof 11